White Plains, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)Winifred Masterson Burke Medical Research, founded in 1986, is a mid-sized nonprofit in the Medical Research sector that reported $19.7M in total revenue in fiscal year 2024. Revenue surged 28% from the prior year, signaling strong growth momentum.
The Burke Neurological Institute BNI is a research institute dedicated to finding cures for chronic neurological disabilities by conducting research involving protection from and repair of neurological diseases such as stroke traumatic brain injury TBI spinal cord injury Alzheimers disease and cerebral palsy. We translate groundbreaking research into clinical treatments to repair the brain and spinal cord to help people walk talk see and remember again.
The Burke Neurological Institute BNI conducts research involving protection from and repair of neurological diseases such as stroke traumatic brain injury TBI spinal cord injury Alzheimers disease...
The Burke Neurological Institute BNI conducts research involving protection from and repair of neurological diseases such as stroke traumatic brain injury TBI spinal cord injury Alzheimers disease and cerebral palsy. In pursuing this goal Burke Neurological Institute seeks to harness the best in contemporary neuroscience to advance interventions to improve brain recovery and recovery function. This endeavor is actively advanced by frequent and lively interchange between scientists working on novel pharmacological biological and robotic approaches to repair the damaged brain and spinal cord. Faculty at Burke Neurological Institute are experts in the repair of neurological impairments and are committed to help translate these approaches to the bedside. A number of important clinical trials have been completed and are ongoing. However we are far from reaching our clinical goals and potential as consequent chronic disability remains a large and almost silent epidemic.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $19,691,529 | $15,401,317 | +0.3% |
| Expenses | $20,905,447 | $17,890,786 | +0.2% |
| Net Income | $-1,213,918 | $-2,489,469 | -0.5% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Robert Baldoni | Board President | 4.00 |
Director
|
$0 | $0 | $0 |
| Anthony B Gioffre III Esq | Secretary | 1.00 |
Director
|
$0 | $0 | $0 |
| Patricia HC Ardigo CCIM | Trustee | 1.00 |
Director
|
$0 | $0 | $0 |
| Rajiv Ratan MD PhD | Chief Executive Officer | 40.00 |
Officer
Director
Highest
|
$517,930 | $76,945 | $594,875 |
| Talal Debs PhD | Trustee | 1.00 |
Director
|
$0 | $0 | $0 |
| Donald E Foley | Trustee | 1.00 |
Director
|
$0 | $0 | $0 |
| Sam Hall | Trustee | 1.00 |
Director
|
$0 | $0 | $0 |
| Christopher J McArthy CPA | Trustee | 1.00 |
Director
|
$0 | $0 | $0 |
| Frederick R Maxfield PhD | Trustee | 1.00 |
Director
|
$0 | $0 | $0 |
| Mary Ann Morris | Trustee | 1.00 |
Director
|
$0 | $0 | $0 |
| Vivien Wong PhD | Trustee | 1.00 |
Director
|
$0 | $0 | $0 |
| Sapan Shah MD | Trustee | 1.00 |
Director
|
$0 | $0 | $0 |
| James Marshel PhD | Research Scientist | 35.00 |
Director
Key Emp
|
$248,749 | $49,447 | $298,196 |
| Yutaka Yoshida PhD | Research Scientist | 35.00 |
Director
Key Emp
|
$233,877 | $56,327 | $290,204 |
| JohnLeahy | Director of Finance | 35.00 |
Director
Key Emp
|
$233,859 | $71,773 | $305,632 |
| Sunghee Cho PhD | Research Scientist | 35.00 |
Director
|
$233,676 | $62,245 | $295,921 |
| Katherine Travis | Research Scientist | 35.00 |
Director
Key Emp
|
$216,142 | $14,693 | $230,835 |
| James Rafferty | Trustee | 1.00 |
Director
|
$0 | $0 | $0 |
| Christpoher Mortko PhD | Trustee | 1.00 |
Director
|
$0 | $0 | $0 |
| Teresa Preskar | Trustee | 1.00 |
Director
|
$0 | $0 | $0 |
| Mary Kate Wold | Tryustee | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $19,691,529 | $20,905,447 | $7,236,831 | $-1,213,918 |
| 2023 | $15,401,317 | $17,890,786 | $7,823,857 | $-2,489,469 |
| 2022 | $14,526,927 | $16,816,237 | $7,862,877 | $-2,289,310 |
| 2021 | $17,375,898 | $17,407,184 | $9,563,124 | $-31,286 |
| 2020 | $17,032,204 | $18,589,968 | $10,897,331 | $-1,557,764 |
| 2019 | $15,706,784 | $18,180,915 | $10,463,393 | $-2,474,131 |
| 2018 | $17,524,752 | $19,034,735 | $14,523,564 | $-1,509,983 |
Compare Winifred Masterson Burke Medical Research with other nonprofits in New York and across the country.